LEUKAEMIC LYMPHOMA

This adverse event was reported 38 times

LEUKAEMIC LYMPHOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 GLUCARPIDASE 1 0.0028
1 EPCORITAMAB-BYSP 3 0.0022
2 POLATUZUMAB VEDOTIN 7 0.0007
3 BENDAMUSTINE HCL 6 0.0004
4 SALINE NASAL SPRAY 1 0.0002
5 CYTARABINE 8 0.0001
6 GEMCITABINE HYDROCHLORIDE 7 0.0001
7 DOXORUBICIN 11 0.0001
8 BENDAMUSTINE HYDROCHLORIDE 1 0.0001
9 CISPLATIN 8 0.0001
See all drugs enriched for association with LEUKAEMIC LYMPHOMA